Chicago Partners Investment Group LLC Forma Therapeutics Holdings, Inc. Transaction History

Chicago Partners Investment Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$5.1 - $10.0 $285 - $560	56 Added 0.55%	10,292 $85,000
Q1 2022 May 20, 2022	SELL	$8.34 - $14.69 $11,208 - $19,743	-1,344 Reduced 11.61%	10,236 $61,000
Q4 2021 Feb 15, 2022	SELL	$13.6 - $24.89 $32,082 - $58,715	-2,359 Reduced 16.92%	11,580 $125,000
Q3 2021 Nov 12, 2021	SELL	$21.22 - $25.7 $5,156 - $6,245	-243 Reduced 1.71%	13,939 $323,000
Q2 2021 Aug 02, 2021	SELL	$22.86 - $30.95 $16,984 - $22,995	-743 Reduced 4.98%	14,182 $337,000
Q1 2021 Apr 28, 2021	SELL	$24.58 - $42.82 $35,518 - $61,874	-1,445 Reduced 8.83%	14,925 $410,000
Q4 2020 Jan 27, 2021	BUY	$34.9 - $51.08 $352,420 - $515,805	10,098 Added 161.0%	16,370 $638,000
Q3 2020 Nov 06, 2020	BUY	$32.95 - $50.25 $206,662 - $315,168	6,272 New	6,272 $282,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.